- TetraLogic Pharmaceuticals (TLOG) prices its 7.15M share IPO at $7 per share. The underwriter greenshoe option is for 1.0725M shares.
- From IPOdesktop's IPO preview: A clinical-stage biopharmaceutical company, TetraLogic is focused on discovering and developing novel small molecule therapeutics that mimic Second Mitochondrial Activator of Caspases, or SMAC-mimetics, and are designed to cause or enable abnormal cells that are resistant to the body's immune system to self-destruct.
- The company currently has no revenue and no collaboration partners.
TetraLogic prices IPO
Dec 12 2013, 07:42 ET